Acasti pharma Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Acasti pharma Contact Number

Contact :: Acasti Pharma Inc. (ACST)

9 hours ago Acastipharma.com Show details

Contact . Acasti Completes Acquisition of Grace Therapeutics, Inc. Read Press Release. Acasti Pharma Inc. 3009 Boul. de la Concorde E. Suite 102 Laval, Québec, Canada H7E 2B5. 685 US Highway One, North Brunswick, NJ 08902. Jan D'Alvise Chief Executive …

Category: Contact SupportShow more

Contacts :: Acasti Pharma Inc. (ACST)

Just Now Acastipharma.com Show details

Acasti is a late-stage specialty pharma company with drug delivery capability and technologies addressing rare and orphan diseases. The Company’s novel drug delivery technologies have the potential to improve the performance of currently…

Category: Contact SupportShow more

Acasti Pharma Inc. (ACST)

9 hours ago Acastipharma.com Show details

Contact . Acasti Completes Acquisition of Grace Therapeutics, Inc. Read Press Release. RESEARCH EXCELLENCE. Acasti is a late-stage specialty pharma company with drug delivery capability and technologies addressing rare and orphan diseases. The …

Category: Contact NumberShow more

Acasti Pharma Inc. Profile SEDAR

3 hours ago Sedar.com Show details

Acasti Pharma Inc. Mailing Address: 3009 boul. de la Concorde E. Suite 102 Laval, Québec H7E 2B5: Head Office Address: 3009 boul. de la Concorde E. Suite 102 Laval, Québec H7E 2B5: Contact Name: Brian D. Ford: Principal Regulator: Quebec: Business e-mail address: [email protected]: Short Form Prospectus Issuer: Yes: Telephone Number

Contact Name: Brian D. Ford
Principal Regulator: Quebec

Category: Contact NumberShow more

Acasti Pharma Crunchbase Company Profile & …

3 hours ago Crunchbase.com Show details

450-686-4555

Contact Email [email protected]acastipharma.com Phone Number 450-686-4555 Acasti Pharma is an emerging biopharmaceutical company dedicated to the research, development, and commercialization of innovative proprietary active pharmaceutical ingredients (API) for the management of cardiometabolic disorders, from prevention to treatment, through a novel

Founded: 2002

Category: Contact NumberShow more

Acasti Pharma Company Profile Office …

Just Now Craft.co Show details

Acasti Pharma has 528 Twitter Followers. The number of followers has increased 2.8% month over month and increased 5% quarter over quarter. Acasti Pharma headquarters is located at 100-545 Promenade Du Centropolis, About us Careers Contact us Blog

Category: Contact NumberShow more

About Us :: Acasti Pharma Inc. (ACST)

Just Now Acastipharma.com Show details

Acasti is a late-stage specialty pharma company with drug delivery capability and technologies addressing rare and orphan diseases. Contact . Acasti Completes Acquisition of Grace Therapeutics, Inc. has written or edited nearly 600 publications, including 481 papers, 85 book chapters, and 27 books. He has received a number of honors and

Category: Contact NumberShow more

Acasti Pharma Inc. (Form: 20F, Received: 06/29/2018 …

7 hours ago Content.edgar-online.com Show details

450-687-2262

Linda P. O’Keefe, Chief Financial Officer Acasti Pharma Inc. 545, Promenade du Centropolis, Suite 100 Laval, Québec H7T 0A3 Tel: 450-687-2262 Fax: 450-687-2272 (Name, Telephone, Email and/or Facsimile number and Address of Company Contact Person) Securities registered or to be registered pursuant to Section 12(b) of the Act.

Category: Contact NumberShow more

Acasti Pharma Inc

Just Now Acastipharma.com Show details

Commission file number: 001-35776 _____ Acasti Pharma Inc. (Exact name of Registrant as specified in its charter) _____ N/A (Translation of Registrant’s name into English) Québec, Canada (Jurisdiction of incorporation or organization) 545, Promenade du Centropolis, Suite 100, Laval, Québec H7T 0A3 (Address of principal executive office)

Category: Contact NumberShow more

ACST Institutional Ownership Acasti Pharma, Inc.

8 hours ago Fintel.io Show details

Acasti Pharma, Inc. (US:ACST) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds (or held) more than 5%

Category: Contact NumberShow more

ACST Short Interest Acasti Pharma, Inc. Short

8 hours ago Fintel.io Show details

ACST / Acasti Pharma, Inc. short sale volume is shown in the following chart. Short Sale volume shows the number of trades marked as short sales in various trading venues. For more information on how to interpret this data, read this information notice provided by FINRA.

Category: Contact NumberShow more

Biotech catalyst calendars and drug pipelines

Just Now Biopharmcatalyst.com Show details

450-686-4555

Acasti Contact: Jan D'Alvise Chief Executive Officer Tel: 450-686-4555 Email: [email protected] www.acastipharma.com. Investor Contact: Crescendo Communications, LLC Tel: 212-671-1020 Email: [email protected] Media Contact : Jules Abraham JQA Partners, Inc. Tel: 917-885-7378 Email: [email protected]

Category: Tech SupportShow more

Acasti Pharma Inc. LinkedIn

Just Now Ca.linkedin.com Show details

Acasti Pharma Inc. 1,091 followers on LinkedIn. Acasti est un innovateur biopharmaceutique dont les activités sont axées sur la recherche, le développement et la commercialisation de médicaments sur ordonnance au moyen d’acides gras oméga-3 tirés de l’huile de krill. Les acides gras oméga-3 font l’objet de nombreuses données cliniques probantes d’innocuité et d’efficacité

Category: Contact NumberShow more

Acasti Pharma Provides Update Following Acquisition …

Just Now Finance.yahoo.com Show details

LAVAL, Québec, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today provided a business update and announced that the

1. Author: Acasti Pharma, Inc.

Category: Contact NumberShow more

ACST Acasti Pharma Inc. • BioPharmCatalyst

5 hours ago Biopharmcatalyst.com Show details

LAVAL, Québec, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ:ACST, TSXV:ACST), today provided a business update and announced that the Nasdaq Stock Market ("Nasdaq") has confirmed to Acasti that the Company has regained compliance with Nasdaq's minimum bid price requirement. Jan D'Alvise, President and Chief Executive Officer of Acasti Pharma

Category: Contact NumberShow more

Acasti Pharma Inc. (Form: 8K, Received: 06/19/2020 …

1 hours ago Content.edgar-online.com Show details

450-686-4555

ACASTI PHARMA INC. (Exact Name of Registrant as Specified in Charter) QUEBEC, CANADA: 001-35776: 98-1359336 (State or Other Jurisdiction of Incorporation) (Commission File Number) Acasti Contact: Jan D’Alvise Chief Executive Officer Tel: 450-686-4555

Category: Contact NumberShow more

Acasti Pharma Provides Update Following Acquisition …

9 hours ago Eminetracanada.com Show details

450-686-4555

Acasti Contact: Jan D’Alvise Chief Executive Officer Tel: 450-686-4555 Email: [email protected] www.acastipharma.com. Investor Contact: Crescendo Communications, LLC Tel: 212-671-1020 Email: [email protected]

Category: Contact NumberShow more

Acasti Pharma Inc. (Form: 10K, Received: 06/29/2020 …

3 hours ago Content.edgar-online.com Show details

The number of outstanding common shares of the registrant, no par value per share, as of June 26, 2020 was 92,488,385. ACASTI PHARMA INC. FORM 10-K . For the Fiscal Year Ended March 31, 2020 . Table of Contents PART I Item 1. Business 6: Item 1A. Risk …

Category: Contact NumberShow more

Acasti Pharma Number of Employees 20142021 …

Just Now Macrotrends.net Show details

Acasti Pharma number of employees from 2014 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis

Category: Contact NumberShow more

Acasti Pharma, Inc. (ACST) Company Profile & Facts …

4 hours ago Finance.yahoo.com Show details

See the company profile for Acasti Pharma, Inc. (ACST) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and

Category: Contact NumberShow more

Acasti Pharma Inc. (ACST): The long term indicators on …

9 hours ago Baxterreport.com Show details

The total number of common shares currently owned by the public is 200.12 million. ACST does have institutional investors; and they hold 2.21% of the stock. Acasti Pharma Inc. – Insider Activity and Holdings. Currently, the stock has been recommended as Moderate Buy …

1. Author: Cody Benson

Category: Contact NumberShow more

Acasti Pharma Stock Analysis 2021 ACST Macroaxis

9 hours ago Macroaxis.com Show details

The newest price gain of Acasti Pharma could raise concerns from private investors as the firm it trading at a share price of 2.12 on 265,415 in volume. The company directors and management may have good odds in positioning the firm resources to exploit market volatility in October.The stock standard deviation of daily returns for 90 days investing horizon is currently 72.32.

Category: Contact NumberShow more

Acasti Pharma Inc. (NASDAQ:ACST) Currently 385.57% …

7 hours ago Marketingsentinel.com Show details

Acasti Pharma Inc.’s shares saw a change of -22.69% in year-to-date performance and have moved -11.06% in past 5-day. Acasti Pharma Inc. (NASDAQ:ACST) showed a performance of -21.18% in past 30-days. Number of shares sold short was 2.98 million shares which calculate 0.27 days to cover the short interests.

Category: Contact NumberShow more

Brian Ford Toronto, Ontario, Canada Professional

4 hours ago Ca.linkedin.com Show details

His significant expertise and experience have made him a highly valued member of the Executive team. He is a professional who is both thorough and inclusive in the way he conducts himself. Under his leadership, we have a strong team in our Finance Department who have significantly expanded the services they can offer the organization. 1 person

Connections: 431
Location: Toronto, Ontario, Canada

Category: Contact NumberShow more

Acasti Pharma Announces Results for Third Quarter of

3 hours ago Finance.yahoo.com Show details

450-686-4555

Acasti Contact:Jan D’AlviseChief Executive OfficerTel: 450-686-4555Email: [email protected]acastipharma.comwww.acastipharma.com Investor Contact:Crescendo Communications, LLCTel: 212-671-1020Email: ACST

Category: Contact NumberShow more

Acasti Pharma Provides Update Following Acquisition of

8 hours ago Globenewswire.com Show details

LAVAL, Québec, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today provided a business update and announced that the

Category: Contact NumberShow more

INVESTIGATION ALERT: Halper Sadeh LLP Investigates …

2 hours ago Finance.yahoo.com Show details

Shareholders are encouraged to contact the firm free of charge to discuss Acasti Pharma Inc. 2.1200-0.1500-6.61%: Su pointed to a number

1. Author: Halper Sadeh LLP

Category: Contact NumberShow more

Acasti Pharma financials 2021 ACST Macroaxis

5 hours ago Macroaxis.com Show details

Acasti Pharma reported Average Assets of 31.68 Million in 2020. Average Equity is likely to gain to about 27.3 M in 2021, whereas Enterprise Value is likely to drop slightly above 64.3 M in 2021. We suggest to use analysis of Acasti Pharma fundamentals to see if …

Category: Contact NumberShow more

Jan D’Alvise Crunchbase Person Profile

5 hours ago Crunchbase.com Show details

Number of Current Jobs 2. Number of Past Jobs 3. Jan D’Alvise has 2 current jobs as President & CEO at Acasti Pharma and VP Life Science Prescreen at Tech Coast Angels. Additionally, Jan D’Alvise has had 3 past jobs including President & CEO at Pediatric Bioscience. Acasti Pharma President & …

Category: Contact NumberShow more

Acasti Pharma Inc (ACST) is higher by 1.11% Friday In

Just Now Investorsobserver.com Show details

Acasti Pharma Inc has a Long-Term Technical rank of 55. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 45% of the market scoring higher. In the Biotechnology industry which is number 134 by this metric, ACST ranks better than 70% of stocks. Important Dates for Investors in ACST:

Category: Contact NumberShow more

Acasti Pharma Stock price prediction (NASDAQ:ACST)

2 hours ago Macroaxis.com Show details

The number of cover stories for Acasti Pharma depends on current market conditions and Acasti Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Acasti Pharma is classified under.

Category: Contact NumberShow more

Acasti Stock Price ACST Macroaxis

Just Now Macroaxis.com Show details

Acasti Pharma is selling for under 1.80 as of the 7th of October 2021; that is -1.1% down since the beginning of the trading day. The stock's last reported lowest price was 1.77. Get the latest Acasti Pharma detailed stock quotes, stock trade data, stock price info, and performance analysis, including Acasti Stock investment advice, charts, stats and more.

Category: Contact NumberShow more

ACST SEC Filings Acasti Pharma, Inc. Annual Report

8 hours ago Fintel.io Show details

CORRESP Acasti Pharma Inc. 3009 boul. De la Concorde E., Suite 102 Laval, Québec, Canada H7E 2B5 July 13, 2021 VIA EDGAR Fredrick Philantrope Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Acasti Pharma Inc. Registration Statement on Form S-4 Filed June 30, 2021 (as amended July

Category: Contact NumberShow more

Acasti Pharma, Inc. (ACST) Balance Sheet Yahoo Finance

1 hours ago Finance.yahoo.com Show details

Acasti Pharma Inc. (ACST) NasdaqCM - NasdaqCM Real Time Price. Currency in USD. Add to watchlist. Visitors trend. 2W 10W 9M. 2.2600 +0.1600 (+7.62%) At close: September 24 …

Category: Contact NumberShow more

What is Acasti Pharma Valuation Today? ACST …

4 hours ago Macroaxis.com Show details

Investors typically determine Acasti Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acasti Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Category: Contact NumberShow more

📉 ACASTI PHARMA INC Share Price ACST Share Price

8 hours ago Stockopedia.com Show details

Shares in Acasti Pharma Inc are currently priced at $2.26. At that level they are trading at 94.97% premium to the analyst consensus target price of 0.00. Analysts covering Acasti Pharma Inc currently have a consensus Earnings Per Share (EPS) forecast of …

Category: Contact NumberShow more

ACST Acasti Pharma Inc. Stock Price & News WSJ

3 hours ago Wsj.com Show details

News Acasti Pharma Inc.ACST. No news for in the past two years. The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the

Category: Contact NumberShow more

Acasti Announces Filing and Mailing of Information …

7 hours ago Globenewswire.com Show details

Acasti Announces Filing and Mailing of Information Circular and Change in Record Date. LAVAL, Québec, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“ Acasti

Category: Contact NumberShow more

Acasti Pharma Announces Successful Completion of its

4 hours ago Eminetracanada.com Show details

After giving effect to the adjustments provided in the merger agreement based on each company’s capitalization and net cash balances, as described in more detail in the Circular, a total of 145,929,867 common shares of Acasti have been issued to Grace stockholders as consideration for the acquisition, bringing the total number of Acasti common shares issued and outstanding to …

Category: Contact NumberShow more

How to buy Acasti Pharma stock (NASDAQ: ACST) …

6 hours ago Finder.com Show details

Over the last 12 months, Acasti Pharma's shares have ranged in value from as little as $1.44 up to $9.76. A popular way to gauge a stock's volatility is its "beta". Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Acasti Pharma's is …

Category: Contact NumberShow more

Acasti Pharma Inc. (ACST) Stock Price, News, Quote, …

Just Now Stockstelegraph.com Show details

Acasti Pharma Inc. (ACST) stock plummeted over -2.78% intraday to trade at $1.75 a share on NASDAQ. The stock opened with a gain of 0.00% at $1.80 and touched an intraday high of $1.8000, declining 0.00% against the last close of $1.80. The stock went to …

Category: Contact NumberShow more

Acasti Pharma Inc (ACST) Price Targets From Analysts

6 hours ago Stocknews.com Show details

Acasti Pharma Inc's upside potential (average analyst target price relative to current price) is higher than 4.9% of Pharmaceutical Products stocks. In the Pharmaceutical Products industry, LFVN , LJPC and OGI are the three stocks most similar to Acasti Pharma Inc regarding the price target and analyst recommendation information presented here.

Category: Contact NumberShow more

Acasti Pharma Announces Successful Completion of its

8 hours ago Globenewswire.com Show details

LAVAL, Québec, Aug. 27, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“ Acasti ”) (NASDAQ: ACST–TSX-V: ACST), announced today the completion of …

Category: Contact NumberShow more

Premarket Mover: Acasti Pharma Inc (ACST) Up 1.71%

8 hours ago Investorsobserver.com Show details

In the Biotechnology industry which is number 131 by this metric, ACST ranks better than 71% of stocks. Important Dates for Investors in ACST:-Acasti Pharma Inc is set to release earnings on 11/15/2021. During their last earnings release the company posted EPS of $-0.79. -We do not have a set dividend date for Acasti Pharma Inc at this time.

Category: Contact NumberShow more

ACST Stock Increases Over 10% PreMarket: Why It …

5 hours ago Pulse2.com Show details

The stock price of Acasti Pharma Inc (NASDAQ: ACST) increased by over 10% pre-market. There are no company-specific news reports from Acasti Pharma. However, investors could be responding positively to an SEC filing — which was an amendment to the Form S-4. In the SEC filing, Acasti Pharma said it is going to seek the shareholder approvals

Category: Contact NumberShow more

Out of the sea and into the factory for Acasti’s heart

1 hours ago Cen.acs.org Show details

Lovaza, a fish-oil-based drug now sold by GlaxoSmithKline, had won U.S. approval in 2005 and was rapidly racking up sales. Lemieux came aboard in 2010 to help lead Acasti

Category: Contact NumberShow more

Acasti (ACST) Moves to Buy: Rationale Behind the …

9 hours ago Nasdaq.com Show details

For the fiscal year ending March 2021, this biopharmaceutical company is expected to earn -$0.19 per share, which is a change of 17.4% from the year-ago reported number

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

Where is acasti pharma inclocated in canada?

The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

When does acasti pharma acquire grace therapeutics?

LAVAL, Québec, June 22, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (" Acasti " or the " Company ") (NASDAQ: ACST, TSXV: ACST) today announced its operating and financial results for the fiscal year ended March 31, 2021, and provided an update on its plans to acquire Grace Therapeutics and the ongoing strategic process for CaPre.

What kind of pay does acasti pharma get?

Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD. Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases.

When is the shareholder meeting for acasti pharma?

Acasti will call a shareholder meeting, which will be combined with our FY'21 AGM, to approve the transaction following the public filing of the Form S-4 proxy statement. More information will be provided on the timing and logistics for both events as soon as it is available.

Brand New Updated

Popular Brands

Amazon
Abbvie
Aia
Asml
Att
Amgen
Apple
Adobe
Aptar
Acc
Adidas
Aak
Aes